Título:	Improving the reference standard for the diagnosis of canine visceral leishmaniasis : a challenge for current and future tests
Autor(es):	Teixeira, Ana Izabel Passarella Silva, Debora Marcolino Vital, Tamires Emanuele Nitz, Nadjar Carvalho, Bruna Caroline Véras de Hecht, Mariana Machado Oliveira, Diana Oliveira, Edward Rabello, Ana Romero, Gustavo Adolfo Sierra
ORCID:	http://orcid.org/0000-0003-1425-926X
Assunto:	Leishmaniose visceral Cão Testes diagnósticos Sorologia
Data de publicação:	2019
Editora:	Instituto Oswaldo Cruz, Ministério da Saúde
Referência:	TEIXEIRA, Ana Izabel Passarella et al. Improving the reference standard for the diagnosis of canine visceral leishmaniasis: a challenge for current and future tests. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 114, e180452, 2019. DOI: https://doi.org/10.1590/0074-02760180452. Disponível em: http://scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762019000100307. Acesso em: 23 jan. 2020.
Abstract:	BACKGROUND Studies aimed at validating canine visceral leishmaniasis diagnostic tests present heterogeneous results regarding test accuracy, partly due to divergences in reference standards used and different infection evolution periods in animals. OBJECTIVE This study aimed to evaluate the accuracy of the rapid test-dual path platform (TR-DPP) (Biomanguinhos®), EIE-Leishmaniose-Visceral-Canina-Biomanguinhos (EIE-LVC) (Biomanguinhos®), enzyme-linked immunosorbent assay (ELISA) rK39 (in-house), and the direct agglutination test (DAT-Canis) against a reference standard comprising parasitological and molecular techniques. METHODS A phase II/III validation study was carried out in sample sera from 123 predominantly asymptomatic dogs living in an area endemic for visceral leishmaniasis. FINDINGS Sixty-nine (56.1%) animals were considered infected according to the reference standard. For each test, the sensitivity and specificity, respectively, were as follows: TR-DPP, 21.74% [confidence interval (CI)95% 13.64% to 32.82%] and 92.59% (CI95% 82.45% to 97.08%); EIE-LVC, 11.59% (CI95% 5.9% to 21.25%) and 90.74% (CI95% 80.09% to 95.98%); ELISA rK39, 37.68% (CI95% 27.18% to 49.48%) and 83.33% (CI95% 71.26% to 90.98%); and DAT-Canis, 18.84% (CI95% 11.35% to 29.61%) and 96.30% (CI95% 87.46% to 98.98%). CONCLUSION We concluded that improving the sensitivity of serum testing for diagnosing asymptomatic dogs must constitute a priority in the process of developing new diagnostic tests to be used in the visceral leishmaniasis control program in Brazil.
Unidade Acadêmica:	Faculdade de Medicina (FMD)
Licença:	(CC BY)
DOI:	https://doi.org/10.1590/0074-02760180452
Aparece nas coleções:	Artigos publicados em periódicos e afins

Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.